Results 81 to 90 of about 99,738,287 (255)

Localization of advanced glycation end-products and their receptor in tendinopathic lesions.

open access: yesHistology and histopathology
This study was designed to investigate the accumulation of advanced glycation end-products (AGEs) and the expression of the receptor of AGEs (RAGE) in tendinopathic tissues. In this study, tendinopathic posterior tibial tendons (PTT) were collected from patients (n=6).
Asomugha, Eva   +5 more
openaire   +3 more sources

High‐Sugar Diet and Intestinal Diseases: A Shared Microbiota–Barrier–Immunity–Metabolism Axis in Inflammatory Bowel Disease, Food Allergy, and Colorectal Cancer

open access: yesiNew Medicine, EarlyView.
ABSTRACT The global incidence of intestinal diseases—including food allergy, inflammatory bowel disease (IBD), and colorectal cancer (CRC)—continues to escalate in parallel with the expansion of the “Western diet,” within which the high‐sugar diet (HSD) has emerged as a pivotal yet under‐recognized dietary driver.
Yuchen Wang   +9 more
wiley   +1 more source

Protein expression of endothelial nitric oxide synthase (eNOS) and receptor for advanced glycation end products (RAGE).

open access: yes, 2012
Protein expression of endothelial nitric oxide synthase (eNOS, panels A and B) and receptor for advanced glycation end products (RAGE, panels C and D) from isolated rats femoral and coronary arteries, respectively.
Ana Paula C. Davel (107962)   +6 more
core   +1 more source

Homodimerization Is Essential for the Receptor for Advanced Glycation End Products (RAGE)-mediated Signal Transduction [PDF]

open access: yes, 2010
The receptor for advanced glycation end products (RAGE) is a pattern-recognition receptor that binds to diverse ligands and initiates a downstream proinflammatory signaling cascade.
Alan W. Stitt   +13 more
core   +1 more source

Advanced glycation end-products and advanced oxidation protein products in schizophrenia

open access: yes, 2022
Schizophrenia pathophysiology is still not well understood. Genetic factors involving biochemical systems are key players and oxidative stress takes part to the development and worsening of SZ.
Pandolfo G.   +17 more
core   +1 more source

The biology of the receptor for advanced glycation end products and its ligands

open access: yesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2000
Receptor for advanced glycation end products (RAGE) is a multiligand member of the immunoglobulin superfamily of cell surface molecules whose repertoire of ligands includes advanced glycation end products (AGEs), amyloid fibrils, amphoterins and S100/calgranulins.
Schmidt, Ann Marie   +3 more
openaire   +2 more sources

Research Progress of Berberine in Kidney Disease: Targeting Mitochondria and Ferroptosis

open access: yesiNew Medicine, EarlyView.
This figure illustrates the model‐specific renoprotective mechanisms of berberine (BBR) across three major kidney diseases. From left to right, the diagram shows that BBR targets distinct core pathways depending on the pathological context: in diabetic nephropathy (DN), BBR activates AMPK to improve mitochondrial energy metabolism; in acute kidney ...
Liuqing Wang   +3 more
wiley   +1 more source

Identification of pyridinoline, a collagen crosslink, as a novel intrinsic ligand for the receptor for advanced glycation end-products (RAGE)

open access: yes, 2018
Advanced glycation end-products (AGEs) elicit inflammatory responses via the receptor for AGEs (RAGE) and participate in the pathogenesis of diabetic complications.
Toshiki Hasegawa   +6 more
core   +1 more source

Geriatric Regenerative Medicine: Mechanisms, Strategies, and Clinical Translation

open access: yesiNew Medicine, EarlyView.
The pathological drivers of aging—stem cell exhaustion, cellular senescence with SASP, and aged extracellular matrix—are precisely targeted by three corresponding mechanism‐based strategies: stem cell therapies (rejuvenation, regeneration, and replacement), senolytic/senomorphic agents (D + Q, fisetin, vaccines, and CAR‐T), and senescence‐targeting ...
Qiang Li   +11 more
wiley   +1 more source

Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes

open access: yes, 2020
Type 1 diabetes (T1D) is one of the most common chronic diseases manifesting in early life, with the prevalence increasing worldwide at a rate of approximately 3% per annum.
Leung, Sherman S.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy